CPP
BCLI
Crow Point Partners’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,829
| Closed | -$104K | – | 75 |
|
|
2019
Q3 | $104K | Hold |
26,829
| – | – | 0.02% | 116 |
|
|
2019
Q2 | $106K | Hold |
26,829
| – | – | 0.02% | 114 |
|
|
2019
Q1 | $116K | Hold |
26,829
| – | – | 0.02% | 114 |
|
|
2018
Q4 | $90K | Hold |
26,829
| – | – | 0.02% | 115 |
|
|
2018
Q3 | $102K | Buy |
26,829
+2,055
| +8% | +$7.81K | 0.02% | 150 |
|
|
2018
Q2 | $98K | Buy |
24,774
+18,327
| +284% | +$72.5K | 0.02% | 115 |
|
|
2018
Q1 | $20K | Buy |
6,447
+1,330
| +26% | +$4.13K | ﹤0.01% | 243 |
|
|
2017
Q4 | $16K | Buy |
+5,117
| New | +$16K | ﹤0.01% | 248 |
|